Literature DB >> 17888976

Mitral valve tenting index for assessment of subvalvular remodeling.

Liam P Ryan1, Benjamin M Jackson, Landi M Parish, Hiroaki Sakamoto, Theodore J Plappert, Martin St John-Sutton, Joseph H Gorman, Robert C Gorman.   

Abstract

BACKGROUND: Ischemic mitral regurgitation results from a variable combination of annular dilatation and remodeling of the subvalvular apparatus. Current surgical techniques effectively treat annular dilatation, but methods for addressing subvalvular remodeling have not been standardized. An effective technique for determining the extent of subvalvular remodeling could improve surgical results by identifying patients who are unlikely to benefit from annuloplasty alone.
METHODS: A well-characterized ovine model of ischemic mitral regurgitation was used. Real-time three-dimensional echocardiography was performed on each animal at baseline and at 1 hour and 8 weeks after infarction. Multiple valvular geometric measurements were calculated at each time point.
RESULTS: Immediate and long-term changes in mitral valvular geometry were observed. Annular height-to-commissural width ratio decreased from 20.0% +/- 1.6% to 11.2% +/- 0.9% 1 hour after infarction (p < 0.001) and to 9.4% +/- 0.4% 8 weeks after infarction (p < 0.001), whereas mitral annular area increased from 8.1 +/- 0.3 cm2 to 9.2 +/- 0.4 cm2 (p < 0.05) and then to 10.5 +/- 0.6 cm2 (p < 0.05). Maximum mitral valve tenting area increased from 49.7 +/- 5.1 mm2 to 58.6 +/- 4.2 mm2 (p < 0.05) and then to 106.4 +/- 3.9 mm2 (p < 0.001), whereas mitral valve tenting volume increased from 679.0 +/- 75.5 mm3 to 828.6 +/- 102.4 mm3 (p = 0.050) and then to 1530.5 +/- 97.8 mm3 (p < 0.001). The mitral valve tenting index increased from 0.83 +/- 0.08 mm to 0.88 +/- 0.08 mm (p > 0.05) and then to 1.46 +/- 0.08 mm (p < 0.001).
CONCLUSIONS: We have described a technique that uses real-time three-dimensional echocardiography to perform a comprehensive assessment of leaflet tethering on the entire mitral valve. Our methodology is not influenced by viewing plane selection, regional tenting asymmetry, or annular dilatation and therefore represents a potentially useful, clinically relevant, and consistent measure of subvalvular remodeling.

Entities:  

Mesh:

Year:  2007        PMID: 17888976     DOI: 10.1016/j.athoracsur.2007.05.005

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  9 in total

1.  Development of a semi-automated method for mitral valve modeling with medial axis representation using 3D ultrasound.

Authors:  Alison M Pouch; Paul A Yushkevich; Benjamin M Jackson; Arminder S Jassar; Mathieu Vergnat; Joseph H Gorman; Robert C Gorman; Chandra M Sehgal
Journal:  Med Phys       Date:  2012-02       Impact factor: 4.071

Review 2.  Mitral valve disease--morphology and mechanisms.

Authors:  Robert A Levine; Albert A Hagége; Daniel P Judge; Muralidhar Padala; Jacob P Dal-Bianco; Elena Aikawa; Jonathan Beaudoin; Joyce Bischoff; Nabila Bouatia-Naji; Patrick Bruneval; Jonathan T Butcher; Alain Carpentier; Miguel Chaput; Adrian H Chester; Catherine Clusel; Francesca N Delling; Harry C Dietz; Christian Dina; Ronen Durst; Leticia Fernandez-Friera; Mark D Handschumacher; Morten O Jensen; Xavier P Jeunemaitre; Hervé Le Marec; Thierry Le Tourneau; Roger R Markwald; Jean Mérot; Emmanuel Messas; David P Milan; Tui Neri; Russell A Norris; David Peal; Maelle Perrocheau; Vincent Probst; Michael Pucéat; Nadia Rosenthal; Jorge Solis; Jean-Jacques Schott; Ehud Schwammenthal; Susan A Slaugenhaupt; Jae-Kwan Song; Magdi H Yacoub
Journal:  Nat Rev Cardiol       Date:  2015-10-20       Impact factor: 32.419

3.  Three-Dimensional Mitral Valve Morphology in Children and Young Adults With Marfan Syndrome.

Authors:  Matthew A Jolley; Peter E Hammer; Sunil J Ghelani; Adi Adar; Lynn A Sleeper; Ronald V Lacro; Gerald R Marx; Meena Nathan; David M Harrild
Journal:  J Am Soc Echocardiogr       Date:  2018-08-08       Impact factor: 5.251

4.  Ischemic mitral regurgitation: a quantitative three-dimensional echocardiographic analysis.

Authors:  Mathieu Vergnat; Arminder S Jassar; Benjamin M Jackson; Liam P Ryan; Thomas J Eperjesi; Alison M Pouch; Stuart J Weiss; Albert T Cheung; Michael A Acker; Joseph H Gorman; Robert C Gorman
Journal:  Ann Thorac Surg       Date:  2011-01       Impact factor: 4.330

5.  Feasibility of in vivo human aortic valve modeling using real-time three-dimensional echocardiography.

Authors:  Arminder S Jassar; Melissa M Levack; Ricardo D Solorzano; Alison M Pouch; Giovanni Ferrari; Albert T Cheung; Victor A Ferrari; Joseph H Gorman; Robert C Gorman; Benjamin M Jackson
Journal:  Ann Thorac Surg       Date:  2014-02-08       Impact factor: 4.330

6.  Intraoperative post-annuloplasty three-dimensional valve analysis does not predict recurrent ischemic mitral regurgitation.

Authors:  Frank Meijerink; Inez J Wijdh-den Hamer; Wobbe Bouma; Alison M Pouch; Ahmed H Aly; Eric K Lai; Thomas J Eperjesi; Michael A Acker; Paul A Yushkevich; Judy Hung; Massimo A Mariani; Kamal R Khabbaz; Thomas G Gleason; Feroze Mahmood; Joseph H Gorman; Robert C Gorman
Journal:  J Cardiothorac Surg       Date:  2020-07-02       Impact factor: 1.637

7.  Predicting clinical outcome by indexed mitral valve tenting in functional mitral valve regurgitation.

Authors:  Maria von Stumm; Florian Dudde; Theresa Holst; Tatjana Sequeira-Gross; Jonas Pausch; Lisa Müller; Christoph R Sinning; Hermann Reichenspurner; E Girdauskas
Journal:  Open Heart       Date:  2021-01

8.  Comparison of surgical results in patients with hypertrophic obstructive cardiomyopathy after classic or modified morrow septal myectomy.

Authors:  Yongqiang Lai; Hongchang Guo; Jinhua Li; Jiang Dai; Changwei Ren; Yang Wang
Journal:  Medicine (Baltimore)       Date:  2017-12       Impact factor: 1.817

9.  Comparison of Modified With Classic Morrow Septal Myectomy in Treating Hypertrophic Obstructive Cardiomyopathy.

Authors:  Bangrong Song; Ran Dong
Journal:  Medicine (Baltimore)       Date:  2016-01       Impact factor: 1.817

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.